Mischa  Reis net worth and biography

Mischa Reis Biography and Net Worth

SVP of Envista
As SVP Strategy & Corporate Development, Mischa Reis leads Envista’s strategic planning and mergers and acquisitions (M&A) activities, including portfolio management, market analysis, deal sourcing, valuation, due diligence, negotiation, and deal execution.

Mischa joined Danaher in 2012 as VP Business Development and Strategy for the Dental Platform, with responsibility for driving its strategy and inorganic growth activities. During his tenure, he completed more than 10 deals spanning four continents, ranging from small minority investments in innovative startups to the $2B+ acquisition of Nobel Biocare.

Prior to Danaher, Mischa worked at Fortune 500 company Avery Dennison for 10 years in a variety of business development, marketing, and strategy roles, most recently as VP and Head of Corporate Strategy. He started his career as a consultant at The Boston Consulting Group in Frankfurt, Germany.

Mischa holds a master’s degree equivalent in Business Administration & Industrial Engineering from the Karlsruhe Institute of Technology, Germany. He lives in Los Angeles, California, with his wife and three kids and is a passionate soccer player (and even more passionate soccer fan of his hometown team, Bayern Munich).

What is Mischa Reis' net worth?

The estimated net worth of Mischa Reis is at least $1.01 million as of August 27th, 2021. Mr. Reis owns 49,059 shares of Envista stock worth more than $1,009,144 as of November 17th. This net worth estimate does not reflect any other investments that Mr. Reis may own. Learn More about Mischa Reis' net worth.

How old is Mischa Reis?

Mr. Reis is currently 51 years old. There are 5 older executives and no younger executives at Envista. The oldest executive at Envista is Mr. Amir Aghdaei, President, CEO & Director, who is 65 years old. Learn More on Mischa Reis' age.

How do I contact Mischa Reis?

The corporate mailing address for Mr. Reis and other Envista executives is 200 S. KRAEMER BLVD. BUILDING E, BREA CA, 92821. Envista can also be reached via phone at 714-817-7000 and via email at [email protected]. Learn More on Mischa Reis' contact information.

Has Mischa Reis been buying or selling shares of Envista?

Mischa Reis has not been actively trading shares of Envista in the last ninety days. Most recently, Mischa Reis sold 2,958 shares of the business's stock in a transaction on Tuesday, March 1st. The shares were sold at an average price of $47.83, for a transaction totalling $141,481.14. Learn More on Mischa Reis' trading history.

Who are Envista's active insiders?

Envista's insider roster includes Amir Aghdaei (CEO), Curt Bludworth (Insider), Eric Conley (SVP), Eric Hammes (CFO), Jeffrey Kappler (SVP), Stephen Keller (Principal Financial Officer), Mark Nance (General Counsel), Mischa Reis (SVP), and Howard Yu (CFO). Learn More on Envista's active insiders.

Are insiders buying or selling shares of Envista?

During the last twelve months, Envista insiders bought shares 1 times. They purchased a total of 24,532 shares worth more than $400,607.56. The most recent insider tranaction occured on August, 12th when CFO Eric D Hammes bought 24,532 shares worth more than $400,607.56. Insiders at Envista own 1.3% of the company. Learn More about insider trades at Envista.

Information on this page was last updated on 8/12/2024.

Mischa Reis Insider Trading History at Envista

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/1/2022Sell2,958$47.83$141,481.14View SEC Filing Icon  
2/25/2022Sell5,009$47.59$238,378.31View SEC Filing Icon  
2/11/2022Sell6,056$47.50$287,660.00View SEC Filing Icon  
12/23/2021Sell10,016$45.00$450,720.00View SEC Filing Icon  
8/27/2021Sell10,016$42.50$425,680.0049,059View SEC Filing Icon  
5/3/2021Sell1,049$43.73$45,872.7749,159View SEC Filing Icon  
9/20/2019Buy1,000$22.00$22,000.00
See Full Table

Mischa Reis Buying and Selling Activity at Envista

This chart shows Mischa Reis's buying and selling at Envista by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Envista Company Overview

Envista logo
Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products. This segment also provides software packages, which include DTX Studio Implant; DTX Studio Lab; and DTX Studio Clinic, a software package offered with its imaging products. It offers its products under the Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera, Ormco, Spark, Orascoptic, Damon, Insignia, AOA brands. The Equipment & Consumables segment provides dental equipment and supplies, including digital imaging systems, software, and other visualization/magnification systems; endodontic systems and related products; restorative materials, rotary burs, impression materials, bonding agents, and cements; and infection prevention products. This segment offers its products under the Dexis, DTX Studio, Kerr, Metrex, Total Care, Pentron, Optibond, Harmonize, Sonicfill, Sybron Endo, and CaviWipes to dental offices, clinics, and hospitals. Envista Holdings Corporation was incorporated in 2018 and is headquartered in Brea, California.
Read More

Today's Range

Now: $20.57
Low: $19.95
High: $20.67

50 Day Range

MA: $19.20
Low: $16.98
High: $21.89

2 Week Range

Now: $20.57
Low: $15.15
High: $25.64

Volume

1,874,091 shs

Average Volume

2,357,661 shs

Market Capitalization

$3.54 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.3